Literature DB >> 20345336

Bipolar transurethral resection in saline: the solution to avoid hyponatraemia and transurethral resection syndrome.

Dirk P J Michielsen1, Danny Coomans, Johan G Braeckman, Vincent Umbrain.   

Abstract

OBJECTIVE: To compare serum sodium changes and the incidence of transurethral resection (TUR) syndrome after monopolar transurethral resection of the prostate (TURP) and bipolar transurethral resection in saline (TURIS) for symptomatic benign prostatic hyperplasia.
MATERIAL AND METHODS: Between January 2005 and August 2009, 550 consecutive patients with symptomatic benign prostate hyperplasia underwent TURP, by either a monopolar or bipolar technique. Preoperative and postoperative blood parameters were analysed to compare preoperative and postoperative electrolyte concentrations.
RESULTS: Over 56 months, 265 patients underwent a conventional monopolar TURP and 285 patients had a bipolar TURIS (Olympus). Patient profiles regarding age, operation time, resection weight and resection speed were similar in both groups. A drop in sodium of 2.5 mmol/l was measured in the conventional monopolar resection group. The decline of 1.5 mmol/l in the bipolar group, although smaller, was still statistically significant (p = 0.001). With longer operation times (> 1 h) the difference between the groups became more important (p < 0.001). Two clinical TUR syndromes were observed in the monopolar group, while none occurred in the bipolar group.
CONCLUSIONS: Bipolar TURP in saline is a safe technique and obviates the risk of TUR syndrome. Repeated serum analysis of electrolytes after TURIS can be omitted.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20345336     DOI: 10.3109/00365591003720275

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  8 in total

1.  "Underwater" endoscopic submucosal dissection: a novel method for resection in saline with a bipolar needle knife for colorectal epithelial neoplasia.

Authors:  Shunsuke Yoshii; Tomofumi Akasaka; Yoshito Hayashi; Yoshiki Tsujii; Kengo Nagai; Koji Higashino; Ryu Ishihara; Hideki Iijima; Tetsuo Takehara
Journal:  Surg Endosc       Date:  2018-09-26       Impact factor: 4.584

2.  Five-year follow-up results of a randomized controlled trial comparing bipolar plasmakinetic and monopolar transurethral resection of the prostate.

Authors:  Chang-Ying Xie; Guang-Bin Zhu; Xing-Huan Wang; Xiang-Bin Liu
Journal:  Yonsei Med J       Date:  2012-07-01       Impact factor: 2.759

3.  Fluid extravasation caused by bladder perforation during bipolar transurethral resection using saline solution -a case report-.

Authors:  Sun-Kyung Park; Woo-Jin Cho; Yun-Suk Choi
Journal:  Korean J Anesthesiol       Date:  2013-08-27

4.  Bipolar versus monopolar resection of benign prostate hyperplasia: a comparison of plasma electrolytes, hemoglobin and TUR syndrome.

Authors:  Meltem Savran Karadeniz; Erdem Bayazit; Omur Aksoy; Emine Aysu Salviz; Tzevat Tefik; Oner Sanli; Mukadder Orhan Sungur; Kamil Mehmet Tugrul
Journal:  Springerplus       Date:  2016-10-07

Review 5.  Management of BPH then 2000 and now 2016 - From BPH to BPO.

Authors:  Johan Braeckman; Louis Denis
Journal:  Asian J Urol       Date:  2017-03-30

6.  Systematic review and meta-analysis on bipolar versus monopolar transurethral resection of bladder tumors.

Authors:  Wojciech Krajewski; Łukasz Nowak; Marco Moschini; Andrea Mari; Ettore Di Trapani; Evanguelos Xylinas; Andrzej Tukiendorf; Sławomir Poletajew; Romuald Zdrojowy
Journal:  Transl Androl Urol       Date:  2021-01

7.  Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction.

Authors:  Cameron Edwin Alexander; Malo Mf Scullion; Muhammad Imran Omar; Yuhong Yuan; Charalampos Mamoulakis; James Mo N'Dow; Changhao Chen; Thomas Bl Lam
Journal:  Cochrane Database Syst Rev       Date:  2019-12-03

Review 8.  The TURis System for Transurethral Resection of the Prostate: A NICE Medical Technology Guidance.

Authors:  Andrew Cleves; Paul Dimmock; Neil Hewitt; Grace Carolan-Rees
Journal:  Appl Health Econ Health Policy       Date:  2016-06       Impact factor: 2.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.